# NDA211912
> **NDA211912** · New Drug Application · Sponsor: CELLTRION INC · Approved 2020-04-13
## Drug
- **FDA Application Number:** NDA211912
- **Application type:** New Drug Application
- **Brand name:** —
- **Generic name:** —
- **Active ingredients:** —
- **Dosage form:** —
- **Route:** —
- **Marketing status:** —
- **Sponsor:** CELLTRION INC
- **First approval:** 2020-04-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211912)
---
*MORVS · CC0 1.0*